Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
AJNR. American Journal of Neuroradiology|February 25, 2022
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, A Ziaei, et al.
Neuro-Oncology|March 21, 2022
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) StudyJason R Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cancer|December 7, 2018
A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosisDeepak Chellapandian, Melissa R Hines, Rui Zhang, et al.
Blood|July 25, 2023
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patientsFrancesco Pegoraro, Martina Mazzariol, Irene Trambusti, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
International Journal of Cancer|July 22, 2010
Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutationGreta R Bunin, Marc A Felice, William Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Improving global access to genomic profiling in rare pediatric cancersSameer Farouk Sait, Tara J O'Donohue, Tejus Bale, et al.
Ophthalmology|May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable RetinoblastomaEmily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
AJNR. American Journal of Neuroradiology|February 25, 2022
ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, A Ziaei, et al.
Neuro-Oncology|March 21, 2022
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) StudyJason R Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Neuro-Oncology|February 25, 2021
A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium studyJason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Cancer|December 7, 2018
A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosisDeepak Chellapandian, Melissa R Hines, Rui Zhang, et al.
Blood|July 25, 2023
Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patientsFrancesco Pegoraro, Martina Mazzariol, Irene Trambusti, et al.
Pediatric Blood & Cancer|September 24, 2017
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastomaKim Kramer, Neeta Pandit-Taskar, John L Humm, et al.
International Journal of Cancer|July 22, 2010
Medical radiation exposure and risk of retinoblastoma resulting from new germline RB1 mutationGreta R Bunin, Marc A Felice, William Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Improving global access to genomic profiling in rare pediatric cancersSameer Farouk Sait, Tara J O'Donohue, Tejus Bale, et al.
Ophthalmology|May 19, 2020
Recommendations for Long-Term Follow-up of Adults with Heritable RetinoblastomaEmily S Tonorezos, Danielle Novetsky Friedman, Dana Barnea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPGHolly B Lindsay, Catherine A Billups, Mehmet Kocak, et al.
Pageof 24